Clinical Topic Overview
Type 2 Diabetes
Primary care physicians are on the front lines of a diabetes epidemic. Approximately 24 million people—8 percent of the U.S. population—have diabetes, and approximately one-quarter of these cases are undiagnosed. The costs of the disease, in both human and economic terms, are vast. In addition to being the seventh leading cause of death in the U.S., it is the leading cause of blindness and kidney failure and is associated with 60 percent of all amputations. Heart disease mortality and stroke risk are two to four times higher among those with diabetes than those without. In economic terms, diabetes accounts for $174 billion in direct and indirect expenditures, including lost work days and productivity in the U.S.1 As the prevalence in the U.S. and around the world continues to rise,2, 3 these costs will only continue to grow.
Primary care physicians most frequently see patients at risk for and with type 2 diabetes. As such, they are in the best position to improve diagnosis and management of patients with type 2 diabetes. However, a 2009 needs assessment of primary care physicians conducted by PennCME/BestPractice revealed the following gaps:
-
Physicians often fail to screen patients at risk for diabetes to improve rates of early diagnosis and treatment.
-
Inadequate glucose control as measured by regular administration of A1C tests and eye and foot exams to avoid and better manage complications of disease in type 2 patients.
-
Inadequate lipid management, BP control, depression screening, smoking cessation, and weight management guidance to minimize CV and CKD risks and manage other comorbid conditions in type 2 diabetes patients.
-
Physicians need to improve knowledge and understanding of treatment options, such as when to initiate insulin therapy and how to match patient needs and characteristics to the most appropriate antidiabetic agent.
-
Physicians need to address systems issues in their practices in order to provide integrated delivery of care to patients with type 2 diabetes.
-
Poor communication between patients and health care providers contributes to patient non-adherence to medication regimes, lifestyle changes and self monitoring.
Type 2 Diabetes Resources from Penn CME/BestPractice
| Performance Improvement | Patient Resource Center |
| Staff Resource Center | Extended Resources |
CME Content - Type 2 Diabetes
Hot Topics
Breaking Diabetes News
-
Metformin should be the first-line choice in oral therapy for type 2 diabetics who don't respond to diet and lifestyle changes, according to a new guideline.
-
Exercising for one straight hour in hypoxic conditions improves glycemic control among patients with type 2 diabetes, researchers found.
-
WASHINGTON -- The FDA has approved an extended-release version of a combination sitagliptin and metformin for adults with type 2 diabetes.
-
The FDA has approved Jentadueto, a combination of metformin plus a dipeptidyl peptidase-4 (DPP-4) inhibitor for type 2 diabetes, makers of the drug announced.
-
Several rare genetic mutations affecting the circadian rhythm pathway substantially boost diabetes risk, researchers found.
-
WASHINGTON -- The delay is over for the diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.
-
Reported difficulty falling or staying asleep or sleeping too much was associated with heightened cardiometabolic risk, a large, nationally representative survey showed.
-
Even a couple of traditional cardiovascular risk factors in middle age spell high lifetime risk for the heart, researchers affirmed.
-
Patients with diabetes are less likely to face foot or leg amputations than they once were, although they're still at higher risk of losing a limb than the general population, researchers found.
-
Patients with hyperglycemia but no known coronary disease may still have heart damage, which can be picked up with a highly sensitive troponin test, a population study showed.
